DOSE OF REALITY: REPORT FINDS BIG PHARMA RIDER IN TAX LAW LIKELY TO COST SENIORS AND TAXPAYERS FAR MORE THAN PREVIOUSLY ESTIMATED
The Wall Street Journal Finds Pharma-Backed Provision Likely to Enable Big… Read More
The Wall Street Journal Finds Pharma-Backed Provision Likely to Enable Big… Read More
AbbVie and Bristol Myers Squibb Report Better-Than-Expected Earnings in the… Read More
Pair of Big Pharma Giants Beat Expectations After Hiking Prices on Nearly 50… Read More
Lawmakers Can Build on Track Record of Bipartisan Collaboration by Advancing… Read More
Washington Post Editorial Misses Connection Between DTC Advertising and Higher… Read More
Roche Continues Hiking Prices on Blockbuster Drugs While Beating Wall Street… Read More
Pharmaceutical Giant Beats Wall Street Expectations While Hiking Prices on… Read More
Coalition Commends Bipartisan Group of Lawmakers for Commitment to Cracking… Read More
FTC Listening Session Highlights How Big Pharma Undermines Competition from… Read More
Pharma-Backed Policy Would Cost Seniors and Taxpayers Billions of Dollars in… Read More
Analysis Underscores How Anti-Competitive Tactics Like Patent Thicketing Keep… Read More
Legislation Would Remove Regulatory Barriers to Foster Greater Competition… Read More